Neovascularization and angiogenic factors in advanced human carotid artery stenosis

Circulation Journal

Volumn 76, Issue 5, 2012, Pages 1274-1282

  Pelisek, Jaroslav ^a   Well, Georg ^a   Reeps, Christian ^a   Rudelius, Martina ^a   Kuehnl, Andreas ^a   Culmes, Mihaela ^a   Poppert, Holger ^a   Zimmermann, Alexander ^a   Berger, Hermann ^a   Eckstein, Hans Henning ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Atherosclerosis; Carotid artery; Neovascularization; Plaque vulnerability

Indexed keywords

ANGIOGENIC FACTOR; ANGIOPOIETIN 1; ANGIOPOIETIN 2; CALCIUM; COLLAGEN; ELASTIN; PLATELET DERIVED GROWTH FACTOR; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 2;

AGED; ANGIOGENESIS; ARTICLE; ATHEROSCLEROTIC PLAQUE; BLOOD ANALYSIS; CAROTID ARTERY DISEASE; CAROTID ARTERY OBSTRUCTION; CAROTID ATHEROSCLEROSIS; CELL INFILTRATION; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFLAMMATION; INFLAMMATORY CELL; MACROPHAGE; MAJOR CLINICAL STUDY; MALE; REAL TIME POLYMERASE CHAIN REACTION; SMOOTH MUSCLE;

AGED; ANGIOGENESIS INDUCING AGENTS; CAROTID STENOSIS; ENDOTHELIAL CELLS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MACROPHAGES; MALE; MIDDLE AGED; MUSCLE, SMOOTH, VASCULAR; NEOVASCULARIZATION, PATHOLOGIC; PLAQUE, ATHEROSCLEROTIC;

EID: 84860174750     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-11-0768     Document Type: Article

References (32)

1. Langheinrich AC, Kampschulte M, Buch T, Bohle RM. Vasa vasorum and atherosclerosis: Quid novi? Thromb Haemost 2007; 97: 873-879.
2. Virmani R, Kolodgie FD, Burke AP, Finn AV, Gold HK, Tulenko TN, et al. Atherosclerotic plaque progression and vulnerability to rupture: Angiogenesis as a source of intraplaque hemorrhage. Arterioscler Thromb Vasc Biol 2005; 25: 2054-2061.
3. Sluimer JC, Daemen MJ. Novel concepts in atherogenesis: Angiogenesis and hypoxia in atherosclerosis. J Pathol 2009; 218: 7-29.
4. Di Stefano R, Felice F, Balbarini A. Angiogenesis as risk factor for plaque vulnerability. Curr Pharm Des 2009; 15: 1095-1106.
5. Chen CH, Walterscheid JP. Plaque angiogenesis versus compensatory arteriogenesis in atherosclerosis. Circ Res 2006; 99: 787-789.
6. Fujita M, Sasayama S. Coronary collateral growth and its therapeutic application to coronary artery disease. Circ J 2010; 74: 1283-1289.
7. Carmeliet P. Angiogenesis in health and disease. Nat Med 2003; 9: 653-660.
8. Heilmann C, Beyersdorf F, Lutter G. Collateral growth: Cells arrive at the construction site. Cardiovasc Surg 2002; 10: 570-578.
9. Pelisek J, Shimizu M, Nikol S. Differential developmental origin of arteries: Impact on angiogenesis and arteriogenesis. Med Chem Rev 2004; 1: 317-326.
10. Schaper W, Scholz D. Factors regulating arteriogenesis. Arterioscler Thromb Vasc Biol 2003; 23: 1143-1151.
11. Ferrara N. Vascular endothelial growth factor. Arterioscler Thromb Vasc Biol 2009; 29: 789-791.
12. Shibuya M. Vascular endothelial growth factor-dependent and-independent regulation of angiogenesis. BMB Rep 2008; 41: 278-286.
13. Cross MJ, Dixelius J, Matsumoto T, Claesson-Welsh L. VEGF-receptor signal transduction. Trends Biochem Sci 2003; 28: 488-494.
14. Armulik A, Abramsson A, Betsholtz C. Endothelial/pericyte interactions. Circ Res 2005; 97: 512-523.
15. Karamysheva AF. Mechanisms of angiogenesis. Biochemistry 2008; 73: 751-762.
16. Lim HS, Lip GY, Blann AD. Angiopoietin-1 and angiopoietin-2 in diabetes mellitus: Relationship to VEGF glycaemic control endothelial damage/dysfunction and atherosclerosis. Atherosclerosis 2005; 80: 113-118.
17. Randomised trial of endarterectomy for recently symptomatic carotid stenosis: Final results of the MRC European Carotid Surgery Trial (ECST) Lancet 1998; 351: 1379-1387.
18. Virmani R, Burke AP, Farb A, Kolodgie FD. Pathology of the vulnerable plaque. J Am Coll Cardiol 2006; 47: C13-C18.
19. Redgrave JN, Gallagher PJ, Lovett JK, Rothwell PM. Critical cap thickness and rupture in symptomatic carotid plaques: The Oxford Plaque Study. Stroke 2008; 39: 1722-1729.
20. Pelisek J, Rudelius M, Zepper P, Schuster T, Seidl S, Reeps C, et al. Multiple biological predictors for vulnerable carotid lesions. Cerebrovasc Dis 2009; 28: 601-610.
21. Stary HC. Natural history and histological classification of atherosclerotic lesions: An update. Arterioscler Thromb Vasc Biol 2000; 20: 1177-1148.
22. Heider P, Pelisek J, Poppert H, Eckstein HH. Evaluation of serum matrix metalloproteinases as biomarkers for detection of neurological symptoms in carotid artery disease. Vasc Endovasc Surg 2009; 43: 551-560.
23. Reeps C, Pelisek J, Seidl S, Schuster T, Zimmermann A, Kuehnl A, et al. Inflammatory infiltrates and neovessels are relevant sources of MMPs in abdominal aortic aneurysm wall. Pathobiology 2009; 76: 243-252.
24. Roy R, Zhang B, Moses MA. Making the cut: Protease-mediated regulation of angiogenesis. Exp Cell Res 2006; 312: 608-622.
25. Libby P. Inflammation in atherosclerosis. Nature 2002; 420: 868-874.
26. Ritman EJ, Lerman A. The dynamic of vasa vasorum. Cardiovasc Res 2007; 75: 649-658.
27. Holm PW, Slart RH, Zeebregts CJ, Hillebrands JL, Tio RA. Atherosclerotic plaque development and instability: A dual role for VEGF. Ann Med 2009; 41: 257-264.
28. Miyazaki S, Kasai T, Miyauchi K, Miyazaki T, Akimoto Y, Takagi A, et al. Changes of matrix metalloproteinase-9 level is associated with left ventricular remodeling following acute myocardial infarction among patients treated with trandolapril, valsartan or both. Circ J 2010; 74: 1158-1164.
29. Raines EW. PDGF and cardiovascular disease. Cytokine Growth Factor Rev 2009; 15: 237-254.
30. Sprague AH, Khalil RA. Inflammatory cytokines in vascular dysfunction and vascular disease. Biochem Pharmacol 2009; 78: 539-552.
31. Yamagishi S, Imaizumi T. Pericyte biology and diseases. Int J Tissue React 2005; 27: 125-135.
32. Moreno PR, Purushothaman KR, Zias E, Sanz J, Fuster V. Neovascularization in human atherosclerosis. Curr Mol Med 2006; 6: 457-477.